Literature DB >> 9822960

Ocular fundus lesions in systemic lupus erythematosus model mice.

A Nakamura1, T Yokoyama, S Kodera, D Zhang, S Hirose, T Shirai, A Kanai.   

Abstract

We investigated the ocular fundus of (NZWXBXSB) F1 mice, which are considered to be a good model for systemic lupus erythematosus (SLE) with antiphospholipid syndrome. The abnormal fundus findings were documented by fundus photography, and the chorioretinal lesions were studied histopathologically. The incidence of ocular fundus abnormalities and systemic signs in these F1 mice was significantly higher in males than in females, as with the systemic symptoms. This indicated an influence of the Yaa (Y chromosome-linked autoimmune acceleration) gene. Lesions in the fundus appeared as white spots, which increased in number during the course of the disease and developed into retinal detachment in some animals. This developmental course resembled the course of patients with multifocal posterior pigment epitheliopathy. Dilatation of the veins and narrowing of arteries were marked. Histopathological findings included: (1) destruction of the photoreceptor cell layer, (2) degeneration and loss of the retinal pigment epithelium, (3) thickening of the wall of the choroidal arterioles, and (4) narrowing and occlusion of the choriocapillaris associated with hyaline degeneration and thrombus formation. The study of the SLE mouse model should contribute to the understanding of the abnormalities in the fundus associated with collagen diseases.

Entities:  

Mesh:

Year:  1998        PMID: 9822960     DOI: 10.1016/s0021-5155(98)00023-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  1 in total

1.  A portable, contact animal fundus imaging system based on Rol's GRIN lenses.

Authors:  Victor Hernandez; Thomas Albini; William Lee; Cornelis Rowaan; Derek Nankivil; Esdras Arrieta; Jean-Marie Parel
Journal:  Vet Ophthalmol       Date:  2011-08-08       Impact factor: 1.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.